Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
19 Cards in this Set
- Front
- Back
Insulin - ordered by t-half
|
Lispro (rapid)
Aspart (rapid) Regular (short) NPH (intermediate) Glargine (long) Determi (long) |
|
Sulfonylureas
MOA? clinical use? toxicities? names? |
close K+ channel in beta-cell membrane --> cell depolarizes --> insulin release via Ca++ influx
type II diabetes - stimulates insulin release (not useful in type I b/c requires some islet cell fxn) 1st gen - disulfiram like effects 2nd gen - hypoglycemia 1st gen: Tolbutamide, Chlorpropamide 2nd gen: Glyburide, Glimepiride, Glipizide |
|
Biguanides
MOA? clinical use? toxicities? names? |
exact MOA unknown
decrease gluconeogenesis, increase glycolysis, increase peripheral glucose uptake oral. 1st line therapy in type 2 DM. can be used in pts w/o islet fxn (type 1) most grave adverse effect - lactic acidosis contraindicated in renal failure Metformin |
|
what is first line therapy in type 2 DM?
|
Metformin
|
|
what is contraindication for metformin?
|
renal failure
can cause grave lactic acidosis |
|
Thiazolidinediones
-names? -MOA? -clinical use? -toxicities? |
Pioglitazone, Rosiglitazone
increase insulin sensitivity in peripheral tissue binds to PPAR-gamma nuclear transcription regulator (adiponectin) used as monotherapy in type 2 DM, or combined w/agents above can cause weight gain, edema. Hepatotoxicity, heart failure |
|
alpha-glucosidase inhibitors
-names? -MOA -clinical use? -toxicities? |
acarbose, miglitol
inhibit intestinal brush border alpha-glucosidases delayed sugar hydrolysis & glucose absorption, decreased postprandial hyperglycemia monotherapy in type 2 DM, or in combination can cause GI disturbances |
|
Pramlinide?
|
mimetic;
decreases glucagon used in type 2 DM can cause hypoglycemia, nausea, diarrhea |
|
Exenatide?
|
GLP-1 analog
increases insulin, decreases glucagon release used in type 2 diabetes can cause nausea, vomiting, pancreatitis |
|
potassium perchlorate?
|
block iodine absorption by thyroid
(anion inhibitor) |
|
iodide salts?
|
decrease synthesis & release of thyroid hormones
(anion inhibitor) |
|
Methimazole? (other similar agent?)
MOA? clinical use? toxicity? |
also, propylthiouracil
blocks peroxidase, inhibiting organification of iodide & coupling of thyroid hormone synthesis propylthiouracil also blocks 5' deiodinase, decreasing peripheral conversion of T4 to T3 used for hyperthyroidism can cause: -skin rash, agranulocytosis (rare), aplastic anemia propylthiouracil can cause hepatotoxicity methimazole is a possible teratogen |
|
Levothyroxine, triiodothyrine
MOA? clinical use? toxicity? |
thyroxine replacement
used for hypothyroidism, myxedema can cause tachycardia, heat intolerance, tremors, arrhythmia |
|
GH?
|
used in GH deficiency and Turner syndrome
|
|
Octreotide?
|
somatostain
used to tx acromegaly, carcinoid, gastrinoma, glucagonoma |
|
Oxytocin?
|
stimulates labor, uterine contractions, & milk-let down
controls uterine hemorrhage |
|
ADH (desmopressin)?
|
used for central DI
also apparently can help in pts w/ von Willebrands / hemophilia too |
|
Democlocycline?
|
ADH antagonist (member of tetracycline family - not used as antibiotic anymore)
used for siADH can cause nephrogenic DI, photosensitivity, abnormaliteis of bone & teeth |
|
Beclomethasone, triamcinolone, dexamethasone, hydrocortisone, prednisone?
|
Glucocorticoids
inhibits phospholipase A2 & expression of COX-2, decreasing produciton of leukotrienes & prostaglandins used for addison's dz, inflammation, immune suppression, asthma can cause iatrogenic cushing's syndrome, adrenocortical atrophy, peptic ulcers, diabetes, thin skin, easy brusing adrenal insufficiency when drug stopped after chronic use |